doxepin has been researched along with Cognition Disorders in 2 studies
Doxepin: A dibenzoxepin tricyclic compound. It displays a range of pharmacological actions including maintaining adrenergic innervation. Its mechanism of action is not fully understood, but it appears to block reuptake of monoaminergic neurotransmitters into presynaptic terminals. It also possesses anticholinergic activity and modulates antagonism of histamine H(1)- and H(2)-receptors.
doxepin : A dibenzooxepine that is 6,11-dihydrodibenzo[b,e]oxepine substituted by a 3-(dimethylamino)propylidene group at position 11. It is used as an antidepressant drug.
Cognition Disorders: Disorders characterized by disturbances in mental processes related to learning, thinking, reasoning, and judgment.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yanai, K | 1 |
| Okamura, N | 1 |
| Tagawa, M | 1 |
| Itoh, M | 1 |
| Watanabe, T | 1 |
| Shafey, H | 1 |
2 other studies available for doxepin and Cognition Disorders
| Article | Year |
|---|---|
New findings in pharmacological effects induced by antihistamines: from PET studies to knock-out mice.
Topics: Animals; Behavior, Animal; Brain; Cognition Disorders; Doxepin; Histamine Antagonists; Humans; Male; | 1999 |
The effect of fluoxetine in depression associated with multiple sclerosis.
Topics: Adult; Cognition Disorders; Depressive Disorder; Doxepin; Female; Fluoxetine; Humans; Multiple Scler | 1992 |